​
​

VYNE Therapeutics Ownership | Who Owns VYNE Therapeutics?

OverviewForecastRevenueFinancialsChart

VYNE Therapeutics Ownership Summary

VYNE Therapeutics is owned by 0.09% institutional investors, 8.32% insiders, and 91.60% retail investors. Staley capital advisers is the largest institutional shareholder, holding 0.09% of VYNE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in VYNE Therapeutics shares.

VYNE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVYNE Therapeutics0.09%8.32%91.60%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Staley capital advisers36.47K0.09%$71.85K
Ashton thomas private wealth---
Cornerstone planning group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Staley capital advisers36.47K0.00%$71.85K
Ashton thomas private wealth---
Cornerstone planning group---

Top Buyers

HolderShares% AssetsChange
Staley capital advisers36.47K0.00%-
Cornerstone planning group---2.00
Ashton thomas private wealth---19.00

Top Sellers

HolderShares% AssetsChange
Ashton thomas private wealth---19.00
Cornerstone planning group---2.00
Staley capital advisers36.47K0.00%-

Sold Out

HolderChange
Cornerstone planning group-2.00
Ashton thomas private wealth-19.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20242-36,4910.05%-68.00%1---
Mar 31, 20242100.00%36,4740.01%-28.75%1---
Dec 31, 20231-36,47255.39%1216.22%1---
Sep 30, 20231-23,472--137.87%----
Jun 30, 20231-23,472--138.68%----100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv373.32K2.53%-
AlphaCentric LifeSci Healthcare I310.50K2.11%-134.50K
AlphaCentric Life Sciences & Hlthcare I310.50K2.11%-134.50K
Fidelity Extended Market Index71.72K0.49%-11.45K
Vanguard Institutional Extnd Mkt Idx Tr69.19K0.47%-
iShares Micro-Cap ETF35.55K0.24%-
NT Ext Equity Mkt Idx Fd - NL22.69K0.15%-
Fidelity Total Market Index19.83K0.13%-
NT Ext Equity Mkt Idx Fd - DC - NL - T218.28K0.12%56.00
Fidelity Series Total Market Index16.66K0.11%7.08K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 15, 2023LEPORE PATRICK G-Buy$50.78K
Mar 20, 2023LEPORE PATRICK G-Buy$49.68K
Mar 20, 2023Harsch Mutya Chief Legal Officer and GCBuy$25.00K
Nov 30, 2021LEPORE PATRICK G-Buy$12.70K
Aug 25, 2021LEPORE PATRICK G-Buy$20.00K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q41-
2023 Q2--

VYNE Ownership FAQ

Who Owns VYNE Therapeutics?

VYNE Therapeutics shareholders are primarily institutional investors at 0.09%, followed by 8.32% insiders and 91.59% retail investors. The average institutional ownership in VYNE Therapeutics's industry, Biotech Stocks , is 45.43%, which VYNE Therapeutics falls below.

Does Blackrock own VYNE Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VYNE Therapeutics.

Who is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested?

Staley capital advisers is VYNE Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 36.47K VYNE Therapeutics shares, valued at 71.85K$.

Who is the top mutual fund holder of VYNE Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of VYNE Therapeutics shares, with 2.53% of its total shares outstanding invested in 373.32K VYNE Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools